Dachaigh › Gnìomhan › Chemists › South San Francisco, CA
Chemists ann an South San Francisco, CA: Tuarastalan H-1B
93 iarrtasan cumhaichean-obrach airson an dreuchd seo le làrach-obrach ann an South San Francisco, CA. Tuarastal bunasach meadhanach $141,500; leth meadhanach $119,800–$152,186.
A rèir ìre tuarastail
| Ìre tuarastail | Tuarastal meadhanach |
|---|---|
| Ìre I (innte) | $84,000 |
| Ìre II (càileachail) | $104,499 |
| Ìre III (eòlach) | $143,150 |
| Ìre IV (gu lèir comasach) | $148,117 |
Suidhichidh Roinn an Obrach ceithir ìrean tuarastail làithreach airson gach dreuchd agus sgìre, bho Ìre I (inntrigeadh) gu Ìre IV (gu tur comasach). Taghaidh an neach-fastaidh an ìre a fhreagras ri riatanasan na h-obrach.
Luchd-fastaidh
| Neach-obrach | LCAs | Tuarastal meadhanach |
|---|---|---|
| Genentech, Inc. | 23 | $143,100 |
| Amgen Inc. | 10 | $157,459 |
| MRL San Francisco, LLC | 9 | $126,970 |
| Cytokinetics, Inc. | 6 | $119,970 |
| Abbvie Biotherapeutics Inc. | 6 | $145,000 |
| Ideaya Biosciences Inc. | 4 | $148,060 |
| R2M Pharma, Inc. | 4 | $126,970 |
| Denali Therapeutics Inc. | 3 | $123,614 |
| Eli Lilly and Company | 3 | $148,264 |
| Apertor Pharmaceuticals Inc. | 2 | $162,500 |
| Firefly Biologics, Inc. | 2 | $167,500 |
| Insitro, Inc. | 2 | $141,558 |
| Vilya, Inc. | 2 | $110,132 |
| Circle Pharma, Inc. | 2 | $137,958 |
| Alpha Consulting Corporation | 2 | $93,600 |
| Mantra Bio, Inc. | 1 | $125,000 |
| Mammoth Biosciences Inc. | 1 | $104,499 |
| Sanofi US Services Inc. | 1 | $84,282 |
| Thermo Fisher Scientific Inc. | 1 | $73,715 |
| Frontier Medicines Corporation | 1 | $150,000 |
| ORIC Pharmaceuticals, Inc. | 1 | $145,700 |
| Nkarta, Inc. | 1 | $138,362 |
| Lyterian Therapeutics | 1 | $280,800 |
| Bayone Solutions, Inc. | 1 | $228,800 |
| Terremoto Biosciences, Inc. | 1 | $160,888 |
| Soley Therapeutics, Inc | 1 | $150,000 |
| AbbVie Inc. | 1 | $146,000 |
| Onepot AI, Inc. | 1 | $170,000 |
Tiotalan dreuchd
- Scientist12
- Senior Scientist6
- Scientist, Molecular Discovery3
- Scientist I3
- Sr. Scientist II, Medicinal Chemistry2
- Senior Scientist, Analytical R&D2
- Principal Scientist, Chemistry2
- Technical Development Scientist2
- Senior Scientist, Chemistry2
- Principal Research Scientist, Medicinal Chemistry2
- Senior Scientist I, Biologics Drug Product Development2
- Associate Scientist - III (Senior) CA2
- Principal Scientist2
- Scientist III, Chemistry1
- Senior Scientific Researcher1
Luchd-taic H-1B ann an South San Francisco, CA →
Is e na tuarastalan an ìre as ìsle den tuarastal a chaidh a thabhann air gach iarrtas, air an tionndadh gu suim bhliadhnail; cleachdaidh na staitistigean iarrtasan làn-aimsire le teisteanas a-mhàin. Chan eil LCA na aontachadh bhìosa agus faodaidh aon LCA còmhdach a dhèanamh air iomadh dreuchd. Stòr: Roinn an Obrach na SA, Dàta Foillseachaidh OFLC LCA, bliadhnaichean ionmhais 2023–2026 (co-dhùnadh as ùire 30 Ògmh 2026).